BDBM307701 (3R)-N-[5-chloro-4-(1-methyl-1H-benzimidazol-6-yl)pyridin-2-yl]piperidine-3-carboxamide::US9650358, Example 3
SMILES: Cn1cnc2ccc(cc12)-c1cc(NC(=O)[C@@H]2CCCNC2)ncc1Cl
InChI Key: InChIKey=MSMDWUISWULBMX-CYBMUJFWSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cyclin-dependent kinase 9 (Homo sapiens (Human)) | BDBM307701![]() ( (3R)-N-[5-chloro-4-(1-methyl-1H-benzimidazol-6-yl...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 38 | n/a | n/a | n/a | n/a | n/a | n/a |
AbbVie Inc. US Patent | Assay Description CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in... | US Patent US9650358 (2017) BindingDB Entry DOI: 10.7270/Q2057J0M | |||||||||||
More data for this Ligand-Target Pair |